Arctic Bioscience AS (OSL:ABS) Total Liabilities: kr111.17 Mil (As of Dec. 2025)


OSL:ABS Arctic Bioscience AS OSL:ABS
56 GF Score
Price kr3.19
GF Value kr10.62
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Arctic Bioscience AS Total Liabilities?

Arctic Bioscience AS OSL:ABS -1.85% 56 Total Liabilities is kr111.17 Mil as of Dec. 2025. GuruFocus rates OSL:ABS with a GF Score™ of 56/100 and a GF Value™ of kr10.62 (Possible Value Trap). The stock has 6 warning signs investors should review.

Arctic Bioscience AS's Total Liabilities for the quarter that ended in Dec. 2025 was kr111.17 Mil.

Arctic Bioscience AS's quarterly Total Liabilities increased from Dec. 2024 (kr69.01 Mil) to Jun. 2025 (kr95.05 Mil) and increased from Jun. 2025 (kr95.05 Mil) to Dec. 2025 (kr111.17 Mil).

Arctic Bioscience AS's annual Total Liabilities increased from Dec. 2023 (kr41.69 Mil) to Dec. 2024 (kr69.01 Mil) and increased from Dec. 2024 (kr69.01 Mil) to Dec. 2025 (kr111.17 Mil).

Arctic Bioscience AS Total Liabilities Historical Data

* Premium members only.

The historical data trend for Arctic Bioscience AS's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arctic Bioscience AS Total Liabilities Chart

Arctic Bioscience AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial 20.92 40.42 41.69 69.01 111.17

Arctic Bioscience AS Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.69 38.12 69.01 95.05 111.17
OSL:ABS
56GF Score
Arctic Bioscience AS OSL:ABS
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arctic Bioscience AS Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Arctic Bioscience AS's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=82.97+(27.351+0.845
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=111.17

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=284.655-173.489
=111.17

Arctic Bioscience AS's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=82.97+(27.351+0.845
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=111.17

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=284.655-173.489
=111.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of kr111.17 Mil mean?
Arctic Bioscience AS (OSL:ABS) has a Total Liabilities of kr111.17 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Arctic Bioscience AS and its competitors.
Is Arctic Bioscience AS's Total Liabilities too high?
Arctic Bioscience AS's current Total Liabilities is kr111.17 Mil. Overall, Arctic Bioscience AS has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Arctic Bioscience AS's Total Liabilities compare to VRTX and REGN?
Arctic Bioscience AS's Total Liabilities of kr111.17 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Arctic Bioscience AS and its competitors. Arctic Bioscience AS's current Total Liabilities is kr111.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arctic Bioscience AS stock overvalued right now?
Based on GuruFocus' analysis, Arctic Bioscience AS (OSL:ABS) is currently considered Possible Value Trap. The stock's GF Value™ is kr10.62, compared to a current price of kr3.19 — trading 70% below its estimated fair value. The current Total Liabilities is kr111.17 Mil. Arctic Bioscience AS's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Arctic Bioscience AS (OSL:ABS), the current Total Liabilities is kr111.17 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arctic Bioscience AS (OSL:ABS) Overvalued in 2026?

Based on GuruFocus' analysis, Arctic Bioscience AS stock appears to be undervalued. The current stock price of kr3.19 is trading 70% below its estimated GF Value™ of kr10.62. GuruFocus considers Arctic Bioscience AS to be Possible Value Trap.

Key valuation signals for OSL:ABS:

  • Total Liabilities: kr111.17 Mil
  • GF Value™: kr10.62 vs. price of kr3.19 (70% below fair value)
  • GF Score™: 56/100 with 6 warning signs

No single metric tells the full story. See the OSL:ABS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arctic Bioscience AS Business Description

Other Exchanges 9TD:Germany
Address Industrivegen 42, Orsta, NOR, 6155
Arctic Bioscience AS is a clinical-stage biotechnology company working to develop drug candidates within the areas of autoimmune and inflammatory diseases. It is developing pharmaceutical and commercializing nutraceutical products based on bioactive marine compounds, including lipids essential to maintaining cell membranes. The company's proprietary extraction technology is used to extract membrane fats from marine raw materials, such as herring roe and algae. Geographically, the company operates in Norway, the Americas, Europe, and APAC, with the majority of the revenue derived from the Americas.
56GF Score

Get the complete analysis for OSL:ABS

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.19
Price
kr10.62
GF Value